Results 21 to 30 of about 276,512 (289)

Development, Production, and Postmarketing Surveillance of Hepatitis A Vaccines in China

Journal of Epidemiology, 2014
China has long experience using live attenuated and inactivated vaccines against hepatitis A virus (HAV) infection. We summarize this experience and provide recent data on adverse events after immunization (AEFIs) with hepatitis A vaccines in China.
F. Cui, Xiaofeng Liang, Fu-zhen Wang, Hui-hui Zheng, Y. Hutin, Weizhong Yang   +5 more
semanticscholar   +1 more source

Neonatal hepatitis B vaccination: Reevaluating timing and adjuvants for enhanced safety and effectiveness

Pediatric Discovery, 2023
Our aim is an achievement of a 100 percent vaccination rate without toxic vaccine effects. We did a comprehensive literature review on aluminum neurotoxicity and early neonatal hepatitis B vaccination.
Aleksandar Cirovic, Ana Cirovic, Ana Ivanovski, Petar Ivanovski   +3 more
doaj   +1 more source

Widespread Hepatitis A Outbreaks Associated with Person-to-Person Transmission — United States, 2016–2020

MMWR. Morbidity and mortality weekly report, 2022
Hepatitis A is a vaccine-preventable disease typically acquired through fecal-oral transmission. Hepatitis A virus (HAV) infection rates in the United States declined approximately 97% during 1995-2015 after the introduction and widespread pediatric use ...
M. Foster, M. Hofmeister, Shaoman Yin, Martha P. Montgomery, Mark K. Weng, Maribeth Eckert, N. Nelson, J. Mermin, C. Wester, E. Teshale, Neil Gupta, L. Cooley, R. Augustine, Nathan E. Crawford, D. Green, Y. Khudyakov, S. Ramachandran, K. Rapposelli, Karena F. Sapsis, Frank Whitlatch, M. Morrison, Nakema S. Moss, Priscilla Lauro, Olivia Arizmendi, J. Zipprich, Rachel H Jervis, Ann Q. Shen, Nikki M. Kupferman, Megan Gumke, N. Kikuchi, Ami Gandhi, Jared Bartschi, Randi Pedersen, D. Nims, N. Stone, Lauren Maxwell, Chelsea Raybern, J. Khoury, Amanda Odegård, Raychel N. Berkheimer, Chloe Manchester, D. Blythe, Kompan Ngamsnga, Lindsay Bouton, Erin Mann, Cole Burkholder, Macey Ladisky, Sam Burt, G. Grilli, Jannifer Anderson, Theresa S. Kittle, Devin Raman, Zuwen Qiu-Shultz, E. Daly, John J. Dreisig, Deepam Thomas, Marla Sievers, Jamie N. Sommer, Cori J. Tice, J. Albertson, Susan Sullivan, Brandi Taylor, L. Orkis, K. Waller, LaKita D. Johnson, Rachel A Radcliffe, Allison Sierocki, Bree Barbeau, J. Eason, K. Holloman, Marshall P. Vogt, M. Chan, Shannon M. McBee, Melissa A. Scott   +73 more
semanticscholar   +1 more source

METHODS FOR ASSESSMENT OF THE SPECIFIC ACTIVITY OF DRUGS FOR PREVENTION OF HEPATITIS B

Вопросы вирусологии, 2017
The immunologic activity (specific activity) is one of the main indicators of quality of vaccines for prophylaxis of hepatitis B, along with their safety.
E. L. Postnova, N. V. Shalunova, K. A. Sarkisyan, A. A. Movsesyants   +3 more
doaj   +1 more source

A Review of Racial and Ethnic Disparities in Immunizations for Elderly Adults

Journal of Primary Care & Community Health, 2021
Vaccine preventable diseases are responsible for a substantial degree of morbidity in the United States as over 18 million annual cases of vaccine preventable disease occur in the U.S. annually.
Oluchi Elekwachi, La’Marcus T. Wingate, Veronica Clarke Tasker, Lorraine Aboagye, Tadesse Dubale, Dagmawit Betru, Razan Algatan   +6 more
doaj   +1 more source

Long-term protective effects of hepatitis A vaccines. A systematic review.

Vaccine, 2012
OBJECTIVE Data on duration and long-term protective effects of hepatitis A vaccines (HepA) have not been reviewed using a systematic approach. Our objective is to provide a comprehensive review of evidence on the duration of protection achieved by HepA ...
J. J. Ott, G. Irving, S. Wiersma
semanticscholar   +1 more source

Prevenção das hepatites virais através de imunização Viral hepatitis prevention by immunization

Jornal de Pediatria, 2006
OBJETIVO: Apresentar uma revisão atualizada e crítica da prevenção das hepatites virais A e B, através de imunização. FONTE DOS DADOS: Revisão de artigos médicos obtidos através do banco de dados MEDLINE, sendo selecionados os mais atuais e ...
Cristina Targa Ferreira, Themis Reverbel da Silveira   +1 more
doaj   +1 more source

WHO position paper on hepatitis A vaccines: June 2012-recommendations.

Vaccine, 2013
This article presents the World Health Organizations (WHO) recommendations onthe use of hepatitis A vaccine excerpted from the WHO position paper on hepatitis A vaccines - June 2012 recently published in the Weekly Epidemiological Record [1]. The current

semanticscholar   +1 more source

Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms

Viruses, 2020
Hepatitis B remains one of the major global health problems more than 40 years after the identification of human hepatitis B virus (HBV) as the causative agent.
J. Ho, Beena Jeevan-Raj, H. Netter
semanticscholar   +1 more source

Live attenuated hepatitis A vaccines developed in China

Human Vaccines & Immunotherapeutics, 2013
Two live, attenuated hepatitis A vaccines, H2 and LA-1 virus strains, were developed through serial passages of the viruses in cell cultures at 32 °C and 35 °C respectively.
Zhi-yi Xu, Xuan-Yi Wang
semanticscholar   +1 more source